BHF Outperforms Industry, Trades at a Discount: How to Play the Stock

Brighthouse Financial (BHF) has outperformed its industry and the S&P 500 over the past year, gaining 37.7%, and trades at a discount with a forward price-to-book value of 0.63X compared to the industry average of 1.97X. Revenue estimates for 2025 indicate a 1.4% year-over-year improvement, while earnings and revenue are projected to increase by 14.5% and 1.8% respectively in 2026; however, recent analyst sentiment is bearish, with downward revisions to 2025 and 2026 earnings estimates.

Analysis

Brighthouse Financial (BHF) has significantly outperformed its industry and broader market indices over the past year, with its shares appreciating 37.7%, and currently trades at an attractive forward price-to-book value of 0.63X, substantially below the industry average of 1.97X. The stock exhibits positive technical momentum, trading above its 50-day ($56.18) and 200-day ($52.08) simple moving averages as of its recent close at $57.67. Operationally, BHF is benefiting from an expanding individual insurance market, enhanced by new products like Shield Level Pay Plus and SecureKey which have driven annuity sales, and boasts a strong trailing twelve-month return on equity of 25.6%, compared to the industry's 15.37%. Revenue growth is projected at 1.4% for 2025, with earnings per share anticipated to increase by 14.5% in 2026. However, this outlook is tempered by recent bearish analyst activity; consensus earnings estimates for 2025 and 2026 have been revised down by 2.7% and 0.8% respectively over the past 30 days. Furthermore, the average analyst price target of $58.50 implies limited near-term upside, and BHF has a mixed record of earnings surprises, beating estimates in two of the last four quarters with an average surprise of 9.3%.

Key Decisions for Investors

• Investors should weigh BHF's strong historical stock performance, attractive valuation metrics such as its 0.63X forward price-to-book ratio, and positive long-term growth drivers from new products against the recent downward revisions in analyst earnings estimates for 2025 and 2026.
• Despite the stock trading above key moving averages, indicating technical strength, the average analyst price target suggests minimal short-term appreciation, warranting a cautious stance and close monitoring of upcoming earnings reports and any shifts in analyst consensus.
• Consider the company's robust return on equity (25.6%) and commitment to capital returns through share repurchases, but balance these positives with the Zacks Rank #3 (Hold) and the cautious analyst sentiment before making significant portfolio adjustments.